These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25817775)

  • 1. Design, synthesis and 3D-QSAR studies of novel 1,4-dihydropyridines as TGFβ/Smad inhibitors.
    Längle D; Marquardt V; Heider E; Vigante B; Duburs G; Luntena I; Flötgen D; Golz C; Strohmann C; Koch O; Schade D
    Eur J Med Chem; 2015 May; 95():249-66. PubMed ID: 25817775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Second-Generation Cardiomyogenic and Anti-cardiofibrotic 1,4-Dihydropyridine-Class TGFβ Inhibitors.
    Längle D; Werner TR; Wesseler F; Reckzeh E; Schaumann N; Drowley L; Polla M; Plowright AT; Hirt MN; Eschenhagen T; Schade D
    ChemMedChem; 2019 Apr; 14(8):810-822. PubMed ID: 30768867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of b-annulated 1,4-dihydropyridines define cardiomyogenic compounds as novel inhibitors of TGFβ signaling.
    Schade D; Lanier M; Willems E; Okolotowicz K; Bushway P; Wahlquist C; Gilley C; Mercola M; Cashman JR
    J Med Chem; 2012 Nov; 55(22):9946-57. PubMed ID: 23130626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
    Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
    Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationship and quantitative structure-pharmacokinetics relationship of 1,4-dihydropyridines and pyridines as multidrug resistance modulators.
    Zhou XF; Shao Q; Coburn RA; Morris ME
    Pharm Res; 2005 Dec; 22(12):1989-96. PubMed ID: 16158213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activators.
    Visentin S; Ermondi G; Medana C; Pedemonte N; Galietta L; Caron G
    Eur J Med Chem; 2012 Sep; 55():188-94. PubMed ID: 22889557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
    Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydropyridine derivatives to overcome atypical multidrug resistance: design, synthesis, QSAR studies, and evaluation of their cytotoxic and pharmacological activities.
    Mehdipour AR; Javidnia K; Hemmateenejad B; Amirghofran Z; Miri R
    Chem Biol Drug Des; 2007 Oct; 70(4):337-46. PubMed ID: 17937779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and 3D-QSAR study of 1,4-dihydropyridine derivatives as MDR cancer reverters.
    Radadiya A; Khedkar V; Bavishi A; Vala H; Thakrar S; Bhavsar D; Shah A; Coutinho E
    Eur J Med Chem; 2014 Mar; 74():375-87. PubMed ID: 24486418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
    Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
    Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of YAP WW1 domain-binding peptides to target TGFβ/BMP/Smad-YAP interaction in heterotopic ossification.
    Chen D; Liu S; Zhang W; Sun L
    J Pept Sci; 2015 Nov; 21(11):826-32. PubMed ID: 26435515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers.
    El-Moselhy TF; Sidhom PA; Esmat EA; El-Mahdy NA
    Chem Pharm Bull (Tokyo); 2017; 65(10):893-903. PubMed ID: 28966273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridines.
    Manvar AT; Pissurlenkar RR; Virsodia VR; Upadhyay KD; Manvar DR; Mishra AK; Acharya HD; Parecha AR; Dholakia CD; Shah AK; Coutinho EC
    Mol Divers; 2010 May; 14(2):285-305. PubMed ID: 19554465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors.
    Choi SJ; Cho JH; Im I; Lee SD; Jang JY; Oh YM; Jung YK; Jeon ES; Kim YC
    Eur J Med Chem; 2010 Jun; 45(6):2578-90. PubMed ID: 20303626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the hepatoprotective effects of antihypertensive 1,4-dihydropyridine drugs.
    Wei Y; Lu Y; Zhu Y; Zheng W; Guo F; Yao B; Xu S; Wang Y; Jin L; Li Y
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2261-2270. PubMed ID: 30048741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced density gradient as a novel approach for estimating QSAR descriptors, and its application to 1, 4-dihydropyridine derivatives with potential antihypertensive effects.
    Jardínez C; Vela A; Cruz-Borbolla J; Alvarez-Mendez RJ; Alvarado-Rodríguez JG
    J Mol Model; 2016 Dec; 22(12):296. PubMed ID: 27889884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
    Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
    Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
    Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents.
    Trivedi AR; Dodiya DK; Dholariya BH; Kataria VB; Bhuva VR; Shah VH
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5181-3. PubMed ID: 21824772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.